Faculty
Contact
- Email mounabm.rmc@msruas.ac.in
Dr. Mouna B.M.
Assistant Professor
-
School
Medical College
-
Department
Department of Medical Oncology
Dr. Mouna B M is a distinguished Medical Oncologist with specialized expertise in the comprehensive management of solid tumors, hematological malignancies, bone marrow transplantation, immunotherapy, and targeted therapies. She completed her MBBS at M S Ramaiah Medical College, Bengaluru, where she was awarded the Gold Medal and recognized as the Best Outgoing MBBS Graduate (2017), followed by MD (General Medicine, 2021) and DM (Medical Oncology, 2024) at AIIMS, New Delhi, graduating as the topper of her batch. She is deeply committed to advancing the field of oncology through evidence-based practice and research-driven innovation.
Qualification
MBBS – M S Ramaiah Medical College, Bengaluru (2011–2016)
MD (General Medicine) – All India Institute of Medical Sciences (AIIMS), New Delhi (2018–2021)
DM (Medical Oncology) – All India Institute of Medical Sciences (AIIMS), New Delhi (2025)
Experience
Senior Residency (Non-DM), Medical Oncology, AIIMS New Delhi (March 2021 – December 2021)
DM Residency, Medical Oncology, AIIMS New Delhi (2022- Jan 2025)
Assistant Professor Medical Oncology, Ramaiah Medical college and Hospital, Bengaluru (Feb 2025-present)
Training Experience
1. International Collaboration for Research Methods Development in Oncology (CReDO) Workshop, National Cancer Grid (NCG), Mumbai, 2026
2. Pallium India Certification in Pain Management, 2025
3. PG Research Methodology Examination Certification, All India Institute of Medical Sciences, New Delhi, India (2023).
GI, GU breast and lung cancers; lymphomas; immunotherapy; targeted therapy; CAR T-cell therapy; hereditary cancer syndromes; cancer prevention strategies and supportive care
1. Best Outgoing MBBS Graduate, MSRMC – 2017, Secured 11 medals during MBBS – subject topper in 6 subjects and college topper across 3 years
2. Topper of DM (Medical Oncology) batch, AIIMS New Delhi – 2024
3. Poster presentation, ASCO Annual Meeting 2023, Chicago
4. Poster presentation (McBETH), 19th St. Gallen International Breast Cancer Conference 2025, Austria – recipient of Educational Grant
5. e-Poster, AIIMS Research Day 2025
1. Sahu H, Manjunath MB, Ray A et al. Neuroleptic malignant like syndrome causing thrombocytopenia: a rare association. BMJ Case Reports CP 2018;11:bcr-2018-227089.
2. Ray A, Biswas S, Manjunath MB, Meena VP, Sethi P, Sinha S. Utility of nasal application of lignocaine gel using cotton tip swab versus squirting with slip-tip syringe for transnasal fibreoptic bronchoscopy: a pilot randomised controlled trial. Postgraduate Medical Journal 2022;98(1163):675–679.
3. Manjunath M, Ray A. Vitamin D, lung functions, and chronic obstructive pulmonary disease: Quod non erat demonstrandum. Lung India 2020;37(5):459.
4. Mouna Bidaraguppe B M et al. Metformin with neoadjuvant chemotherapy in localized triple negative and HER2neu-positive breast cancer: A prospective phase 2 open label randomised controlled trial (McBETH). JCO 41, TPS631 (2023).
5. Kajal S, Reddy CS, Kumar A, et al (incl. Manjunath MB). Effectiveness of an institutional COVID-19 central sampling team during pandemic at a tertiary care centre. J Family Med Prim Care 2021;10(8):2993–2997.
6. Shwetha BM, Mouna BM et al. A rare case of polymyositis. Afr J Bio Sc 2024;6(Si4).
7. Mouna BM, Batra A, Sharma V, et al. Metformin with neoadjuvant chemotherapy in localized triple-negative and HER2neu-positive breast cancer: A prospective phase 2 open-label randomized controlled trial (McBETH). Cancer 2025;131(24):e70205.
8. Kulkarni AM, Samprathi AH, Paladugu SH, Mouna BM, Devadas S, et al. Treatment strategies for metastatic breast cancer: disparity between India and the West. Proceedings of the Indian National Science Academy, 1–12.
1. Immuno-Oncology Society of India (I-OSI)
2. American Society of Clinical Oncology (ASCO)
3. European Society of Gynaecological Oncology (ESGO)
4. European Society for Medical Oncology (ESMO)
5. Indian Society of Medical & Paediatric Oncology (ISMPO), AMOI
ADDRESS